Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CRKR
|
Paul L. Kessler
Director |
SELL
Open market or private purchase
|
Indirect | 14,211 Reduced 0.53% |
$8,669
$0.61 p/Share
|
Dec 31
2020 |
INVO
|
Trent D Davis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 10,475 Added 43.56% |
-
|
Dec 31
2020 |
INVO
|
Kevin Doody
Medical Director |
BUY
Grant, award, or other acquisition
|
Direct | 8,184 Added 4.6% |
-
|
Dec 31
2020 |
INVO
|
Barbara Ryan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 10,148 Added 44.88% |
-
|
Dec 31
2020 |
INVO
|
Jeffrey Segal
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8,838 Added 46.98% |
-
|
Dec 31
2020 |
INVO
|
Matthew K Szot
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12,112 Added 45.6% |
-
|
Dec 31
2020 |
NBRV
|
Robert Crotty
Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 37 Reduced 0.18% |
$90
$2.42 p/Share
|
Dec 31
2020 |
NBRV
|
Steven P. Gelone
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 63 Reduced 0.18% |
$152
$2.42 p/Share
|
Dec 31
2020 |
NBRV
|
Jennifer Schranz
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 30 Reduced 0.18% |
$73
$2.42 p/Share
|
Dec 31
2020 |
NBRV
|
Theodore R Schroeder
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 121 Reduced 0.19% |
$293
$2.42 p/Share
|
Dec 31
2020 |
NBRV
|
Gary Sender
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 32 Reduced 0.16% |
$77
$2.42 p/Share
|
Dec 31
2020 |
BBI
|
Vijay B Samant
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 4,408 Reduced 18.72% |
$3,438
$0.78 p/Share
|
Dec 31
2020 |
BBI
|
Gary A Lyons
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 5,967 Reduced 24.13% |
$4,654
$0.78 p/Share
|
Dec 31
2020 |
BBI
|
Reginald L Hardy
CHAIRMAN OF THE BOARD |
SELL
Payment of exercise price or tax liability
|
Direct | 4,873 Reduced 2.37% |
$3,801
$0.78 p/Share
|
Dec 31
2020 |
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.04% |
$2,200
$0.22 p/Share
|
Dec 31
2020 |
NRBO
|
Akash Bakshi
SVP and COO |
BUY
Grant, award, or other acquisition
|
Indirect | 855,059 Added 49.17% |
-
|
Dec 31
2020 |
NRBO
|
Akash Bakshi
SVP and COO |
BUY
Grant, award, or other acquisition
|
Direct | 29,013 Added 50.0% |
-
|
Dec 31
2020 |
BICX
|
Louis C. Lucido
President |
BUY
Grant, award, or other acquisition
|
Direct | 4,901 Added 1.84% |
-
|
Dec 31
2020 |
BICX
|
Kent Emry |
BUY
Grant, award, or other acquisition
|
Direct | 4,901 Added 5.27% |
-
|
Dec 31
2020 |
BICX
|
Lourdes Felix
CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 4,901 Added 10.28% |
-
|
Dec 31
2020 |
BICX
|
Brady James Granier |
BUY
Grant, award, or other acquisition
|
Direct | 4,901 Added 5.06% |
-
|
Dec 31
2020 |
LSF
|
Paul Hodge Jr.
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Indirect | 1,608 Reduced 0.6% |
$76,091
$47.32 p/Share
|
Dec 31
2020 |
LSF
|
Paul Hodge Jr.
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 4,545 Added 1.67% |
-
|
Dec 31
2020 |
LSF
|
Valerie Ells
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 909 Reduced 4.96% |
$43,014
$47.32 p/Share
|
Dec 31
2020 |
LSF
|
Valerie Ells
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,409 Added 11.62% |
-
|
Dec 31
2020 |
LSF
|
Andrew J. Mc Cormick
General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 601 Reduced 5.67% |
$28,439
$47.32 p/Share
|
Dec 31
2020 |
LSF
|
Andrew J. Mc Cormick
General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 1,591 Added 13.06% |
-
|
Dec 31
2020 |
JCTCF
|
Charles E. Hopewell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,664 Added 23.98% |
$49,843
$8.8 p/Share
|
Dec 31
2020 |
JCTCF
|
Sarah Kathleen Johnson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 225 Added 50.0% |
$1,980
$8.8 p/Share
|
Dec 31
2020 |
JCTCF
|
Chris Joseph Karlin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 225 Added 50.0% |
$1,980
$8.8 p/Share
|
Dec 31
2020 |
JCTCF
|
Geoffrey Gaddy Guilfoy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 225 Added 50.0% |
$1,980
$8.8 p/Share
|
Dec 31
2020 |
VYNE
|
David Domzalski
PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 9,656 Reduced 0.73% |
$15,256
$1.58 p/Share
|
Dec 31
2020 |
VYNE
|
Mutya Harsch
CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct | 1,822 Reduced 0.56% |
$2,879
$1.58 p/Share
|
Dec 31
2020 |
VYNE
|
Iain Stuart
CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 2,378 Reduced 0.82% |
$3,757
$1.58 p/Share
|
Dec 31
2020 |
VYNE
|
Matthew T. Wiley
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,541 Reduced 0.43% |
$2,435
$1.58 p/Share
|
Dec 31
2020 |
ASPU
|
Michael Mathews
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 182,698 Reduced 16.38% |
$2,033,429
$11.13 p/Share
|
Dec 31
2020 |
ASPU
|
Michael Mathews
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 280,556 Added 20.09% |
$1,007,196
$3.59 p/Share
|
Dec 31
2020 |
BCDA
|
Richard C Pfenniger Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,925 Added 10.23% |
-
|
Dec 31
2020 |
BCDA
|
Andrew Scott Blank
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,643 Added 5.09% |
-
|
Dec 31
2020 |
BCDA
|
Jim L. Allen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,534 Added 0.81% |
-
|
Dec 31
2020 |
BCDA
|
Jay M Moyes
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6,550 Added 11.42% |
-
|
Dec 31
2020 |
BCDA
|
Richard M Krasno
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,534 Added 11.14% |
-
|
Dec 31
2020 |
BCDA
|
Simon H Stertzer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,768 Added 2.79% |
-
|
Dec 31
2020 |
ABEO
|
Paul Elliot Mann
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 609,755 Reduced 78.89% |
-
|
Dec 31
2020 |
ABEO
|
Todd Wider
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 609,755 Reduced 66.26% |
-
|
Dec 31
2020 |
MODD
|
Paul Di Perna
Director |
SELL
Open market or private sale
|
Indirect | 7,220,400 Reduced 48.97% |
-
|
Dec 31
2020 |
BRST
|
Jeffrey H Foster
Director |
BUY
Grant, award, or other acquisition
|
Direct | 31,687 Added 50.0% |
$54,502
$1.72 p/Share
|
Dec 31
2020 |
BRST
|
Thomas M Yockey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 27,035 Added 1.31% |
$46,500
$1.72 p/Share
|
Dec 31
2020 |
BRST
|
Samuel M Spiritos
Director |
BUY
Grant, award, or other acquisition
|
Direct | 27,035 Added 50.0% |
$46,500
$1.72 p/Share
|
Dec 31
2020 |
BRST
|
Daniel J W Neal
Director |
BUY
Grant, award, or other acquisition
|
Direct | 27,035 Added 5.01% |
$46,500
$1.72 p/Share
|
Dec 31
2020 |